Clinical Trial Update: Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a CD70-targeted CAR-T cell therapy using patients' peripheral blood lymphocytes to treat CD70-expressing cancers. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Melanoma
• Ovarian Cancer
• Pancreatic Cancer
• Renal Cell Carcinoma

Drugs mentioned

• CD70-targeted CAR-T cell therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Pancreatic Cancer, Renal Cell Cancer | Phase 1, Phase 2 | Status: RECRUITING